Medicines Distribution Consent




NEW ZEALAND GAZETTE, No. 91

16 JUNE 2005


Health

Medicines Act 1981

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product:
Athlete’s Foot Cream

Active Ingredient:
Terbinafine hydrochloride 1%w/w

Dosage Form:
Topical cream

New Zealand Sponsor:
Multichem NZ Limited

Manufacturer:
Cipla Limited, Patalganga, District Raigad, (Maharashtra), India

Product:
Demazin Infant Clear Syrup

Active Ingredients:
Chlorpheniramine maleate 0.25mg/mL
Phenylephrine hydrochloride 0.5mg/mL

Dosage Form:
Syrup

New Zealand Sponsor:
Schering-Plough Animal Health Limited

Manufacturer:
Schering-Plough Pty Limited, Baulkham Hills, New South Wales, Australia

Product:
Dermafex Cream

Active Ingredient:
Terbinafine hydrochloride 1%w/w

Dosage Form:
Topical cream

New Zealand Sponsor:
Multichem NZ Limited

Manufacturer:
Cipla Limited, Patalganga, District Raigad, (Maharashtra), India

Dated this 9th day of June 2005.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go3675


Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:

Schedule

Product:
Eprex (notification received 4 June 2004)

Active Ingredient:
Epoetin alfa 84µg/mL

Dosage Form:
Solution for injection

New Zealand Sponsor:
Janssen-Cilag Pty Limited

Manufacturers:
Cilag AG, Schaffhausen, Switzerland
Janssen Pharmaceutica NV, Beerse, Belgium
Vetter Pharma-Fertigung GmbH & Co Kg, Ravensburg, Germany

Product:
Eprex (notification received 4 June 2004)

Active Ingredient:
Epoetin alfa 16.8µg/mL

Dosage Form:
Solution for injection

New Zealand Sponsor:
Janssen-Cilag Pty Limited

Manufacturers:
Cilag AG, Schaffhausen, Switzerland
Janssen Pharmaceutica NV, Beerse, Belgium
Vetter Pharma-Fertigung GmbH & Co Kg, Ravensburg, Germany

Product:
Eprex (notification received 4 June 2004)

Active Ingredient:
Epoetin alfa 33.6µg/mL

Dosage Form:
Solution for injection

New Zealand Sponsor:
Janssen-Cilag Pty Limited

Manufacturers:
Cilag AG, Schaffhausen, Switzerland
Janssen Pharmaceutica NV, Beerse, Belgium
Vetter Pharma-Fertigung GmbH & Co Kg, Ravensburg, Germany



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2005, No 91


Gazette.govt.nz PDF NZ Gazette 2005, No 91





✨ LLM interpretation of page content

🏥 Consent to the Distribution of New Medicines

🏥 Health & Social Welfare
9 June 2005
Medicines Act 1981, New medicines, Distribution consent, Health
  • DON MATHESON, Deputy Director-General, Public Health

🏥 Consent to the Distribution of Changed Medicines

🏥 Health & Social Welfare
Medicines Act 1981, Changed medicines, Distribution consent, Health